ARCHIVES

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

This article is from The Cancer Letter archive.

Vol. 20 No. 15 | April 15, 1994

Download PDF Visit The Full Archive

Related Articles

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978